New York, NY, United States of America

Nicholas J Montalto

This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas J Montalto. Retrieved from https://idiyas.com/inventor/nicholas-j-montalto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Nicholas J Montalto

Introduction

Nicholas J Montalto is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment, particularly focusing on colon cancer. His innovative approach utilizes tumor-specific antibodies to combat the effects of this disease.

Latest Patents

Montalto holds a patent for "Methods of treating colon cancer utilizing tumor-specific antibodies." This invention relates to methods of reducing the effects of colon cancer tumors. Various agents are conjugated to monoclonal antibodies that are specific for colon cancer cells. The conjugates are administered to patients having colon cancer, thereby reducing the effects of the cancer.

Career Highlights

Montalto is associated with the Ludwig Institute for Cancer Research Limited, where he continues to work on groundbreaking research in cancer therapies. His dedication to improving treatment options for patients is evident in his innovative work.

Collaborations

Some of his notable coworkers include Sydney Welt and Lloyd J Old. Their collaboration has contributed to advancements in cancer research and treatment methodologies.

Conclusion

Nicholas J Montalto's work exemplifies the impact of innovation in the medical field, particularly in the fight against colon cancer. His contributions are paving the way for more effective treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…